Explore the early-stage startups funded by Arch Grants from 2012 – present.
Developing a rapid and label-free biological assay platform.
DDM accelerates pharmaceutical pipelines with novel software to optimize drug-target binding.
Therapeutic cancer vaccine for the treatment of advanced solid tumors.
Novel cardiac biomarker diagnostic technology.
Omniose is an early-stage biotechnology company developing polysaccharide conjugate vaccines against serious bacterial threats using its proprietary bioconjugation platform.
Prevent Plus, LLC. is a provider of innovative infection prevention polymer science used by professional healthcare providers and patients for wound care, infection prevention and optimized healing across a wide range of clinical applications and specialties.
Radiologics develops FDA-compliant data management systems for medical imaging in clinical trials.
A company inspired to solve important health challenges
Be a Part of the Movement
We champion extraordinary entrepreneurs to create positive change - for St. Louis and for the world. Join us by applying to our Global Startup Competition, becoming a financial supporter, volunteering your time or amplifying our message.